These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 30497962)
1. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962 [TBL] [Abstract][Full Text] [Related]
2. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study. Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734 [TBL] [Abstract][Full Text] [Related]
3. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program. Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170 [TBL] [Abstract][Full Text] [Related]
4. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening. Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mundt MW; Spijker WJ; Bongers EJC; Kuipers EJ; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905 [TBL] [Abstract][Full Text] [Related]
5. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy. Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608 [TBL] [Abstract][Full Text] [Related]
6. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679 [TBL] [Abstract][Full Text] [Related]
7. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357 [TBL] [Abstract][Full Text] [Related]
8. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911 [TBL] [Abstract][Full Text] [Related]
9. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260 [TBL] [Abstract][Full Text] [Related]
10. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China. Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365 [TBL] [Abstract][Full Text] [Related]
11. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426 [TBL] [Abstract][Full Text] [Related]
12. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041 [TBL] [Abstract][Full Text] [Related]
13. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program. Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350 [TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm. Lu M; Zhang YH; Lu B; Cai J; Liu CC; Chen HD; Dai M Chin Med J (Engl); 2021 May; 134(11):1335-1344. PubMed ID: 34039863 [TBL] [Abstract][Full Text] [Related]
15. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program. Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693 [TBL] [Abstract][Full Text] [Related]
16. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round. Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211 [TBL] [Abstract][Full Text] [Related]
17. A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer. Passamonti B; Malaspina M; Fraser CG; Tintori B; Carlani A; D'Angelo V; Galeazzi P; Di Dato E; Mariotti L; Bulletti S; D'Amico MR; Gustinucci D; Martinelli N; Spita N; Cesarini E; Rubeca T; Giaimo M; Segnan N; Senore C Gut; 2018 Mar; 67(3):485-496. PubMed ID: 27974550 [TBL] [Abstract][Full Text] [Related]
18. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. Young GP; Woodman RJ; Symonds E BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195 [TBL] [Abstract][Full Text] [Related]
19. The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study. Wisse PHA; de Klaver W; van Wifferen F; van Maaren-Meijer FG; van Ingen HE; Meiqari L; Huitink I; Bierkens M; Lemmens M; Greuter MJE; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; Carvalho B; de Wit M; Meijer GA Lancet Oncol; 2024 Mar; 25(3):326-337. PubMed ID: 38346438 [TBL] [Abstract][Full Text] [Related]
20. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]